A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers
<p>Abstract</p> <p>Background</p> <p>Familial amyloidosis with polyneuropathy (FAP) is an autosomal dominant disease caused by transthyretin (<it>TTR</it>) mutations, of which V30M (<it>TTR </it>c.148G > A, p.Val50Met, "Val30Met") is...
Saved in:
Main Authors: | Olsson Malin (Author), Norgren Nina (Author), Obayashi Konen (Author), Plante-Bordeneuve Violaine (Author), Suhr Ole B (Author), Cederquist Kristina (Author), Jonasson Jenni (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
by: Paolo Morfino, et al.
Published: (2023) -
siRNA Versus miRNA as Therapeutics for Gene Silencing
by: Jenny K W Lam, et al.
Published: (2015) -
Resveratrol Administration Increases Transthyretin Protein Levels, Ameliorating AD Features: The Importance of Transthyretin Tetrameric Stability
by: Luís Miguel Santos, et al.
Published: (2016) -
The Structural Understanding of Transthyretin Misfolding and the Inspired Drug Approaches for the Treatment of Heart Failure Associated With Transthyretin Amyloidosis
by: Shan He, et al.
Published: (2021) -
Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021)